Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,404,503 papers from all fields of science
Search
Sign In
Create Free Account
lorcaserin hydrochloride 10 MG Oral Tablet [Belviq]
Known as:
Belviq 10 MG (lorcaserin HCl hemihydrate 10.4 MG) Oral Tablet
, Belviq 10 MG Oral Tablet
, LORCASERIN HYDROCHLORIDE HEMIHYDRATE 10 mg ORAL TABLET [Belviq]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
20 relations
Aluminum Oxide
Belviq
Croscarmellose Sodium
FD&C yellow no. 6
Expand
Broader (1)
lorcaserin Oral Tablet [Belviq]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Effects of 5-HT2C receptor modulation and the NA reuptake inhibitor atomoxetine in tests of compulsive and impulsive behaviour
G. Higgins
,
Matt A. Brown
,
J. S. John
,
C. MacMillan
,
L. Silenieks
,
S. Thevarkunnel
Neuropharmacology
2020
Corpus ID: 214659399
2019
2019
Pastilă de slăbit pentru diabetici
Cristian Sever Oană
2019
Corpus ID: 149616424
Lorcaserina (Belviq®) este un agonist selectiv al receptorului de serotonină 2C care modulează apetitul si facilitează scăderea…
Expand
2016
2016
Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists
G. Higgins
,
L. Silenieks
,
Everett B. Altherr
,
C. MacMillan
,
P. Fletcher
,
W. E. Pratt
Psychopharmacology
2016
Corpus ID: 4598801
The 5-HT2C receptor agonist lorcaserin (Belviq®) has been approved by the FDA for the treatment of obesity. Impulsivity is a…
Expand
2015
2015
Lorcaserin (Belviq®) Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys
G. Collins
,
L. Gerak
,
C. France
2015
Corpus ID: 83426625
Drug abuse and obesity are serious public health problems, and mounting evidence suggests that dopamine and serotonin systems are…
Expand
Review
2013
Review
2013
Lorcaserin: A Review of its Use in Chronic Weight Management
Sheridan M. Hoy
Drugs
2013
Corpus ID: 13604784
Oral lorcaserin (BELVIQ®), a selective serotonin 5-HT2C receptor agonist, is indicated in the US as an adjunct to diet and…
Expand
Review
2012
Review
2012
Was it worth the weight? - Drug review on two new weight loss agents: lorcaserin (Belviq®) and phentermine/topiramate ER (QsymiaTM)
A. Crawford
,
Tiffany-Jade Kreys
2012
Corpus ID: 71852021
The prevalence of obesity in the United States (U.S.) is currently at 34%. This article will review two of the newer weight loss…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE